Conversion to sirolimus immunosuppression in liver transplantation recipients with hepatocellular carcinoma: Report of an initial experience

AIM: To report a retrospective analysis of preliminary results of 36 patients who received sirolimus (SRL, Rapamune(®), rapamycin) in a consecutive cohort of 248 liver allograft recipients. METHODS: Thirty-six liver transplant patients with hepatocellular carcinoma (HCC) who were switched to SRL-bas...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Zhou, Jian, Fan, Jia, Wang, Zheng, Wu, Zhi-Quan, Qiu, Shuang-Jian, Huang, Xiao-Wu, Yu, Yao, Sun, Jian, Xiao, Yong-Sheng, He, Yi-Feng, Wang, Yu-Qi, Tang, Zhao-You
Formato: Artigo
Idioma:Inglês
Publicado em: Baishideng Publishing Group Co., Limited 2006
Assuntos:
Rapid Communication
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4124393/
https://ncbi.nlm.nih.gov/pubmed/16718799
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v12.i19.3114
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados